Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.

about

Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.

Item

http://www.wikidata.org/entity/Q48629272

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.

@en

Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.

@nl

type

Item

label

Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.

@en

Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.

@nl

prefLabel

Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.

@en

Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.

@nl

P1476

Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.

@en

P2093

Jo Burke

http://www.w3.org/2001/XMLSchema#string

Karen Wills

http://www.w3.org/2001/XMLSchema#string

Michael Bunting

http://www.w3.org/2001/XMLSchema#string

Paul A James

http://www.w3.org/2001/XMLSchema#string

Penny Blomfield

http://www.w3.org/2001/XMLSchema#string

Stephanie Kearton

http://www.w3.org/2001/XMLSchema#string

P2860

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

Meta-analysis of BRCA1 and BRCA2 penetrance

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Using thematic analysis in psychology

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers

Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.

P2888

s10689-017-0047-1

P31

scholarly article

P356

10.1007/S10689-017-0047-1

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29039136

http://www.w3.org/2001/XMLSchema#string